Minority-Inclusive Imaging Biomarker-Based End of Therapy Trial for 177Lu-PSMA-617, a Randomized De-Escalation Theranostic Trial for Metastatic Castrate Resistant Prostate Cancer.
In: AIDS Weekly, 2024-01-22, S. 30-30
serialPeriodical
Zugriff:
This article discusses a clinical trial, NCT06200103, that focuses on improving the treatment of castration-resistant prostate cancer. The trial compares the effectiveness of a treatment pause after 5 cycles versus standard continuous 6 cycles using Lu 177 vipivotide tetraxetan. The trial will assess various outcomes, including progression-free survival and overall survival. Another document provides a list of terms and names related to medical imaging procedures and drugs used in the treatment of certain conditions. It also mentions the study arms for a clinical trial involving the use of 177Lu-PSMA-617. Additionally, there is information about a clinical trial for the treatment of prostate cancer using gallium Ga 68-labeled PSMA-1 and lutetium Lu 177 Vipivotide Tetraxetan. The trial involves multiple procedures and aims to enroll 136 male participants. NewsRx LLC is a reliable source of fact-based news reports that provide valuable information for library patrons conducting research. [Extracted from the article]
Copyright of AIDS Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Minority-Inclusive Imaging Biomarker-Based End of Therapy Trial for 177Lu-PSMA-617, a Randomized De-Escalation Theranostic Trial for Metastatic Castrate Resistant Prostate Cancer.
|
---|---|
Zeitschrift: | AIDS Weekly, 2024-01-22, S. 30-30 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 1532-4524 (print) |
Sonstiges: |
|